Back
Yext, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
63
YEXT
Yext, Inc.
Last Price:
$8.88
Seasonality Move:
-3.7%
Buy
57
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$104.56
Seasonality Move:
-6.7%
Buy
63
Yext, Inc. (YEXT)
is a Buy
Is Yext, Inc. a Buy, Sell or Hold?
-
The current Yext, Inc. [YEXT] share price is $8.87. The Score for YEXT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
YEXT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $104.60. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
YEXT Stock Price Chart
What is Yext, Inc.'s stock price today?
-
The Yext, Inc. share price today is $8.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and YEXT is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $104.60The current trend is moderately bullish and RYTM is experiencing slight selling pressure.
YEXT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.78 | Buy |
| Relative Strength Index (14 RSI): | 68.46 | Buy |
| Chaikin Money Flow: | -301105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.34 - 8.66) | Buy |
| Bollinger Bands (100): | (8.2 - 8.82) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 50.78 | Buy |
| Chaikin Money Flow: | -195325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.6 - 107.92) | Buy |
| Bollinger Bands (100): | (92.83 - 106.97) | Buy |
YEXT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.61 | Buy |
| 20-day SMA: | 8.51 | Buy |
| 50-day SMA: | 8.47 | Buy |
| 200-day SMA: | 7.74 | Buy |
| 8-day EMA: | 8.57 | Buy |
| 20-day EMA: | 7.15 | Buy |
| 50-day EMA: | 4.38 | Buy |
| 200-day EMA: | 1.4 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.83 | Sell |
| 20-day SMA: | 102.55 | Buy |
| 50-day SMA: | 104.26 | Buy |
| 200-day SMA: | 80.37 | Buy |
| 8-day EMA: | 104.76 | Sell |
| 20-day EMA: | 104.28 | Buy |
| 50-day EMA: | 102.89 | Buy |
| 200-day EMA: | 85.54 | Buy |
Yext, Inc. Earnings Growth & YEXT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.33 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.66 per share.
Yext, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||